Citigroup
ABVX

Citigroup’s Abivax ABVX Stock Holding History

Citigroup’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$193K Buy
1,729
+55
+3% +$6.51K ﹤0.01% 4022
2025
Q4 		$226K Buy
1,674
+1,623
+3,182% +$177K ﹤0.01% 3942
2025
Q3 		$4.33K Sell
51
-170,682
-100% -$10.5M ﹤0.01% 5268
2025
Q2 		$1.31M Sell
170,733
-13,506
-7% -$88K ﹤0.01% 3000
2025
Q1 		$1.15M Buy
+184,239
New +$1.25M ﹤0.01% 3145

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return

Citigroup's ABVX Position: Q1 2026 in Review

Citigroup increased its Abivax (ABVX) stake by 3.3% in Q1 2026, buying an estimated $6.51K and bringing the position to 1,729 shares worth $193K. The position accounts for ﹤0.01% of the portfolio, ranked #4022.

Citigroup first reported a position in ABVX in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.31M in Q2 2025. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

  • Citigroup held 1,729 shares of Abivax worth $193K as of Q1 2026.
  • Citigroup bought 55 Abivax shares in Q1 2026, an estimated $6.51K.
  • Abivax made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4022 holding.
  • Citigroup first reported a position in Abivax in Q1 2025 and has held it in 5 quarters since.
  • Citigroup's Abivax position peaked at $1.31M in Q2 2025.
  • 254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.